"Many public health experts call the study unethical and unnecessary, likening it to the infamous Tuskegee Experiment, while the Trump Administration has promoted it as a rare opportunity to study the potential negative effects of a vaccine. The randomized controlled trial funded partly with $1.6 million from the U.S. Centers for Disease Control and Prevention would study the general health effects of the hepatitis B vaccine given at birth in the west African country of Guinea-Bissau."
""We decided to suspend or even cancel the above mentioned study," said Nantote, who was speaking in Portuguese, through an interpreter. He said a local ethics committee that had approved the study did not have the "required technical resources" and did not coordinate with the necessary other medical authorities in the country. The country experienced a military coup in November last year and many high level officials changed in the process."
A U.S.-funded randomized controlled trial in Guinea-Bissau would study general health effects of the hepatitis B vaccine given at birth, with part of the funding coming from a $1.6 million CDC grant. The proposal generated strong controversy, with public health experts calling it unethical and drawing comparisons to the Tuskegee Experiment while U.S. officials framed it as an opportunity to observe potential vaccine harms. Rumors circulated about the trial's status, and Guinea-Bissau's Minister of Public Health announced suspension pending review. The minister cited an ethics committee's lack of technical resources, poor coordination with medical authorities, misinformation, and inadequate communication. Africa CDC is sending a team to assist.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]